Abstract

Exploration of nanomedicine-based dry powder inhalation formulation co-loaded with erlotinib and curcumin for treatment of non-small cell lung cancer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call